drugset
drugset / Trial / NCT03858049

Efficacy and Safety of Crinone Versus Combination Medication (ACCESS)

NCT03858049 ↗

Phase 4 Terminated 172 enrolled Merck KGaA, Darmstadt, Germany Merck Sharp & Dohme LLC · collab
RandomizedParallel-groupOpen-labelTreatment

Summary

The study to compare to the efficacy and safety of Crinone versus combination medication in infertile women receive frozen-thawed embryo transfer (FET) in artificial cycles (AC).

Timeline

Start
2019-05-31
Primary completion
2021-10-27
Completion
2021-10-27

Outcome

Outcome not reported

Stopped: “The trend in LPS treatment tends to increase the dosage of progesterone in FET-HRT, this study was designed 5 years ago.”

Drugs

EvaluationDrugModalityDoseRoute
Subject Dydrogesterone Other / unclassified 10 mg Oral
Subject Progesterone Other / unclassified 90 mg Other

Indications

female infertility